WHO In Race To Find Promising Ebola Treatments As Many Products Ruled Out 14/11/2014 by Catherine Saez, Intellectual Property Watch 1 Comment Proposals for products to help fight Ebola are coming in to the World Health Organization, but few look promising so far, an official said today. Meanwhile, efforts are on to establish testing sites for potential products, and thinking is still in the early stages on intellectual property rights for new drugs in development.
European Conference Promotes Use Of Standards As A Tool For Innovation 12/11/2014 by Magda Voltolini for Intellectual Property Watch Leave a Comment BRUSSELS – European experts in research, industry and policymaking at a recent conference here discussed the importance of integrating standards, research and business into the cycle of innovation in Europe.
Hard Bargaining In IP Chapter Of Trans-Pacific Partnership, Trade Ministers Say 10/11/2014 by William New, Intellectual Property Watch 2 Comments Intellectual property is still one of the most complex and challenging areas of the Trans-Pacific Partnership (TPP), as some countries are holding fast to high levels of IP protection to promote innovation and creativity, while others continue to seek a greater emphasis on access to ideas. This appears to be the message of today’s statement from trade ministers of countries negotiating the TPP.
Global Differences On Patents Lead WIPO Patent Law Committee To Stumble On Future Work 10/11/2014 by Catherine Saez, Intellectual Property Watch 3 Comments Once again, differences over the role of a World Intellectual Property Organization committee last week came in the way of consensus and prevented delegates from agreeing on future work. At the heart of the discontent was the perceived imbalance of the proposed programme of work, which some said disregarded the interests of developing countries. A speaker for the African region gave a striking speech on the Ebola crisis as an example of the failure of the patent system.
Expect Strong IP Push From Global Pharma Industry Next Year; WHO Prescribes Dose Of Reality 07/11/2014 by William New, Intellectual Property Watch 1 Comment NEW YORK – Strong intellectual property rights will be a top priority for the pharmaceutical industry internationally in the coming year and arguments over IPRs versus medicines access are false, a top representative said at a high-level industry event this week. But views at the event differed on expectations of industry in light of the Ebola crisis, hepatitis C drug costs or other medicines access questions.
WTO, WHO, WIPO Examine IPRs And Middle-Income Countries 06/11/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The current income-based grouping of countries needs to be changed or access to medicines in middle-income countries will worsen, several speakers said yesterday at a joint meeting between three international organisations on health, trade, and intellectual property. But middle-income countries should step up their engagement in organisations such as the World Health Organization, according to WHO and civil society.
Limitations And Exceptions To Patent Rights Discussed In WIPO Committee 04/11/2014 by Catherine Saez, Intellectual Property Watch 1 Comment The World Intellectual Property Organization patent law committee this week is addressing a range of issues including patent quality, technology transfer for medicine production, limitations and exceptions to patents, and the confidentiality of communications between clients and their patent advisors.
TRIPS Council Debates: Tobacco Packaging, Non-Violation Disputes, Innovation, Health Waiver, UNCTAD 30/10/2014 by Catherine Saez, Intellectual Property Watch 1 Comment This week’s meeting of the World Trade Organization body governing intellectual property issues addressed a long agenda, reflecting continued divergence on regular items, such as complaints that do not involve breach of a WTO agreement, a health waiver, and sustained discussions on plain packaging for tobacco products.
European Commission Holds Consultation On Patents And Standards 29/10/2014 by Intellectual Property Watch Leave a Comment The European Commission Directorate General for Enterprise and Industry is gathering stakeholder input on standardisation and intellectual property rights, in order to assess the current framework on patents and standard and look at how it should evolve. Standard-setting cuts across many organisations at the national, European and international levels. Views are being sought until January 2015.
UK Opens Access To 91 Million Orphan Works, UKIPO Says 29/10/2014 by Intellectual Property Watch 2 Comments The United Kingdom today launched a new licensing scheme aimed at opening access to more than 91 million creative works whose owners or copyright holders are not known or not found.